Sanofi Consumer Healthcare India Limited Financial Ratios
SANOFICONR · Healthcare · Current price ₹3,559.9
P/E ratio
34.1x
P/B ratio
28.0x
ROE
62.5%
ROCE
83.9%
Debt / Equity
0.00
Dividend yield
1.8%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 34.1x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 28.0x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 62.5% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 83.9% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.00 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with Sanofi Consumer Healthcare India Limited's latest numbers.
Sanofi Consumer Healthcare India Limited profitability
Sanofi Consumer Healthcare India Limited generates a return on equity of 62.5% and a return on capital employed of 83.9%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.00 and a P/E of 34.1x, Sanofi Consumer Healthcare India Limited is conservatively financed. Our overall business-quality score for the company is 7.0 / 10.
Understand the ratios
More on Sanofi Consumer Healthcare India Limited
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.